PlainVitamins

Vayarin

by VAYA Pharma · capsule · N/A

  • Off the market since November 2023 (NIH)
  • DSLD label 206959
  • Serving 2 capsules

Vayarin by VAYA Pharma lists 3 ingredients, 3 with an amount per serving of 2 capsules. Its current label entered the NIH Dietary Supplement Label Database on September 24, 2019.

What is in Vayarin?

Each row as the label prints it, per serving of 2 capsules. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

Vayarin: Supplement Facts rows against the market (DSLD label 206959, January 2026 release)
IngredientAmount% DVAmong products listing it
LipirinenLipirinen Note: providing167 mg
Phosphatidylserine75 mgPhosphatidylserine in Vayarin against 641 products75 mg per serving; the middle half of products list 50 mg to 150 mg, the median 100 mg.75 mg

65% of 641 products listing phosphatidylserine give more (median 100 mg).

Eicosapentaenoic Acid21.5 mgEPA (Eicosapentaenoic Acid) in Vayarin against 3,134 products21.5 mg per serving; the middle half of products list 120 mg to 590 mg, the median 300 mg.21.5 mg

96% of 3,134 products listing EPA (eicosapentaenoic acid) give more (median 300 mg).

Docosahexaenoic Acid8.5 mgDHA in Vayarin against 3,627 products8.5 mg per serving; the middle half of products list 104 mg to 400 mg, the median 232 mg.8.5 mg

over 99% of 3,627 products listing DHA give more (median 232 mg).

Source: NIH ODS Dietary Supplement Label Database, label 206959 (entered September 24, 2019), version 9.4.0. See the label on DSLD. Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

The rows in the top or bottom tenth of the products that list the same ingredient, and any above the adult upper limit at the most servings a day the directions give:

  • 96% of the 3,134 products that print an amount of EPA (eicosapentaenoic acid) list more than its 21.5 mg of EPA (eicosapentaenoic acid) (median 300 mg).
  • over 99% of the 3,627 products that print an amount of DHA list more than its 8.5 mg of docosahexaenoic acid (filed by NIH under DHA) (median 232 mg).

The NIH database records one serving a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

Which products have the closest formulas?

The products whose ingredient lists overlap most with Vayarin's, rare ingredients counting for more.

Source: ingredient lists of every product's current label in DSLD (version 9.4.0); similarity weights each shared ingredient by how rare it is.

What does the label say about taking it?

Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.

Directions
Dosage and administration Usual dose is 2 capsules daily or as directed by a physician.
Warnings
Vayarin capsules contain shellfish (krill). May contain soy and fish.
Vayarin is a medical food product dispensed by prescription and must be used under physician supervision.
Contraindications Vayarin is contraindicated in patients with know hypersensitivity (e.g., anaphylactic reaction) to Vayarin or any of its components.
Precaution Safety and effectiveness of Vayarin in pregnant or lactating patients have not been established. Therefore, Vayarin is not recommended for these populations.
Vayarin should be used with caution in patients with known hypersensitivity to shellfish.
Warning Keep this product out of the reach of children.
Allergens and what it does not contain
Vayarin capsules do not contain sugar, lactose, yeast or gluten.
Storage
Storage Dispense and keep in original bottle. Store at up to 77(0)F (25(0)). Protect from light and moisture.

Source: label statements in DSLD label 206959.

What else is on the label?

Other ingredients: Phosphatidylserine, Hypromellose, Silicon Dioxide, Rosemary extract, Mixed Tocopherols, Ascorbyl Palmitate, Titanium Dioxide, Caramel.

How many labels does Vayarin have?

One label is on file, entered on September 24, 2019.

  1. Label 206959 (current) Entered September 24, 2019 · off the market November 9, 2023 · N/A

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names VAYA Pharma Inc. (distributor). All VAYA Pharma products.

Where next?